[1] |
ZHONG Wei, SHI Shuxia, QIN Qinyue, YU Guo.
Measurement tools and rationality evaluation of clinical research coordinator's work ability and workload
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 937-947.
|
[2] |
GUO Wei, XIE Linli, CAO Liya, XIE Jiangchuan, XIA Peiyuan, CHEN Yongchuan.
Analysis of the current status of clinical drug trial institutions in Chongqing and reflections on the establishment of regional institutions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1125-1130.
|
[3] |
CHE Jinjing.
Application of biomarkers in clinical development of biologics and bioanalytical strategies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 22-31.
|
[4] |
CHANG Qingqing, PENG Ying, WANG Guangji, SUN Jianguo.
Clinical research progress of small molecule tyrosine kinase inhibitors as anti-hepatocellular carcinoma agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 948-956.
|
[5] |
XIAO Liang, ZHENG Gaozhe, HUANG Yumin.
Research progress on risk-based management in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 955-960.
|
[6] |
SHAN Jiao-jiao,TANG Yi-qun,SHI Mei-qi, XIA Guo-hao, WANG Li,FANG Ying,ZHAO Jie.
Impact of clinical pharmacists on protocol deviation in anti-cancer drug clinical trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 33-37.
|
[7] |
WANG Hui, HU Si-yuan.
Clinical research design technical points on child anorexia treated by new TCM drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1191-1195.
|
[8] |
LI Wei, BO Qing-yan, ZOU Jian-dong, XIONG Ning-ning.
Application of edit checks in clinical research data management
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 76-79.
|
[9] |
.
Key activities involved in conduct of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(3): 357-360.
|
[10] |
BO Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang, WANG Xiu-qin, GAO Wei-min.
Key role in clinical trial:clinical research coordinator
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1190-1193.
|
[11] |
WANG Xiu-qin, XIONG Ning-ning, LIU Shen-lin, LI Qi-yi, JIANG Meng, LIU Fang, GAOWei-min.
Ethic review in clinical research:medical devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1437-1440.
|
[12] |
CHEN Jiong-Hua, XIONG Ning-Ning, ZHOU Jian-Dong, JIANG Meng, LIU Fang, FU Wei-min.
Standard operating procedures for investigators in institution of clinical trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 954-957.
|
[13] |
WANG Yi-Bing, XIONG Ning-Ning, BO Qing-Yan, JIANG Meng, LIU Fang, ZHOU Jian-Dong, FU Wei-Min.
Procedures for investigators training in institutions for clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 474-476.
|
[14] |
WANG Xiu-Qin, XIONG Ning-Ning, LIU Shen-Lin, GAO Wei-Min, JIANG Meng, LIU Fang, ZOU Jian-Dong, BO Qing-Yan.
Ethic review in clinical research:conflicts of interest
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 358-360.
|
[15] |
WANG Xiu-Qin, XIONG Ning-Ning, LIU Shen-Lin, LI Qi-Yi, JIANG Meng, LIU Fang, ZOU Jian-Dong, BO Qing-Yan, GAO Wei-Min.
Ethic review in clinical research:informed consent
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 117-120.
|